JBC Focus on PI3-Kinase with Echelon

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gemmell, C. H.
Right arrow Articles by Yeo, E. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gemmell, C. H.
Right arrow Articles by Yeo, E. L.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 268, Issue 20, 14586-14589, Jul, 1993

Platelet-derived microparticle formation involves glycoprotein IIb- IIIa. Inhibition by RGDS and a Glanzmann's thrombasthenia defect

CH Gemmell, MV Sefton and EL Yeo
Department of Medicine, University of Toronto.

While the physiologic role of platelet microparticles may include a stable, physical dispersion of concentrated surface procoagulant activity the mechanism(s) of platelet vesiculation remains unknown. We demonstrate using flow cytometric methods a central role for the beta 3 integrin glycoprotein (GP) IIb-IIIa complex and its ligand tetrapeptide Arg-Gly-Asp-Ser (RGDS) binding site in platelet vesiculation. Time- and calcium-dependent vesiculation of platelets in response to ADP, collagen, thrombin, phorbol myristate acetate, and the thrombin peptide SFLLRN were dramatically inhibited, in a concentration-dependent manner, by monoclonal antibodies to GPIIb-IIIa (A2A9, 7E3, PAC1) and RGDS. Complete inhibition with A2A9 and RGDS occurred at 7.5 micrograms/ml and 75 microM, respectively, while control antibodies and a mock peptide had no effect. Platelet vesiculation requires intact GPIIb-IIIa and is fully supported by the intracellular pool of GPIIb- IIIa alone since de-complexing of this heterodimer by calcium chelation completely abolished microparticle formation in response to collagen (no alpha-granule release) but not to thrombin or SFLLRN. A central role for GPIIb-IIIa is supported by the near total inability of Glanzmann's thrombasthenic (type I) platelets to vesiculate in response to thrombin, ADP, collagen, and phorbol 12-myristate 13-acetate. This extends the biologic roles of GPIIb-IIIa to include platelet vesiculation and suggests that one or all of its binding ligands play a role.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
B. Salanova, M. Choi, S. Rolle, M. Wellner, F. C. Luft, and R. Kettritz
beta2-Integrins and Acquired Glycoprotein IIb/IIIa (GPIIb/IIIa) Receptors Cooperate in NF-{kappa}B Activation of Human Neutrophils
J. Biol. Chem., September 21, 2007; 282(38): 27960 - 27969.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
S. Eligini, S. S. Barbieri, I. Arenaz, E. Tremoli, and S. Colli
Paracrine up-regulation of monocyte cyclooxygenase-2 by platelets: Role of transforming growth factor-{beta}1
Cardiovasc Res, May 1, 2007; 74(2): 270 - 278.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
E. E. Gardiner, J. F. Arthur, M. L. Kahn, M. C. Berndt, and R. K. Andrews
Regulation of platelet membrane levels of glycoprotein VI by a platelet-derived metalloproteinase
Blood, December 1, 2004; 104(12): 3611 - 3617.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
M. J. VanWijk, E. VanBavel, A. Sturk, and R. Nieuwland
Microparticles in cardiovascular diseases
Cardiovasc Res, August 1, 2003; 59(2): 277 - 287.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Dupont, P. Fontana, C. Bachelot-Loza, J.-L. Reny, I. Bieche, F. Desvard, M. Aiach, and P. Gaussem
An intronic polymorphism in the PAR-1 gene is associated with platelet receptor density and the response to SFLLRN
Blood, March 1, 2003; 101(5): 1833 - 1840.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
B. Nieswandt, W. Bergmeier, K. Rackebrandt, J. E. Gessner, and H. Zirngibl
Identification of critical antigen-specific mechanisms in the development of immune thrombocytopenic purpura in mice
Blood, October 1, 2000; 96(7): 2520 - 2527.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
R. Nieuwland, R. J. Berckmans, S. McGregor, A. N. Boing, F. P. H. Th. M. Romijn, R. G. J. Westendorp, C. E. Hack, and A. Sturk
Cellular origin and procoagulant properties of microparticles in meningococcal sepsis
Blood, February 1, 2000; 95(3): 930 - 935.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Mesri and D. C. Altieri
Endothelial Cell Activation by Leukocyte Microparticles
J. Immunol., October 15, 1998; 161(8): 4382 - 4387.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
T. Geiser, M. Sturzenegger, U. Genewein, A. Haeberli, and J. H. Beer
Mechanisms of Cerebrovascular Events as Assessed by Procoagulant Activity, Cerebral Microemboli, and Platelet Microparticles in Patients With Prosthetic Heart Valves
Stroke, September 1, 1998; 29(9): 1770 - 1777.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
L. Leng, H. Kashiwagi, X.-D. Ren, and S. J. Shattil
RhoA and the Function of Platelet Integrin alpha IIbbeta 3
Blood, June 1, 1998; 91(11): 4206 - 4215.
[Abstract] [Full Text] [PDF]

Home page
 CLIN APPL THROMB HEMOSTHome page
K. Katsura, S. Nomura, Gui Lan Xie, T. Ohtani, T. Ishida, H. Kagawa, C. Kitada, Y. Yamanaka, H. Kitajima, and S. Fukuhara
Platelet Procoagulant Activity During,Peripheral Blood Stem Cell Harvest
Clinical and Applied Thrombosis/Hemostasis, April 1, 1997; 3(2): 124 - 128.
[Abstract] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
P. A. Holme, U. Orvim, M. J. A. G. Hamers, N. O. Solum, F. R. Brosstad, R. M. Barstad, and K. S. Sakariassen
Shear-Induced Platelet Activation and Platelet Microparticle Formation at Blood Flow Conditions as in Arteries With a Severe Stenosis
Arterioscler. Thromb. Vasc. Biol., April 1, 1997; 17(4): 646 - 653.
[Abstract] [Full Text]

Home page
 BloodHome page
H. J. Weiss and B. Lages
Platelet Prothrombinase Activity and Intracellular Calcium Responses in Patients With Storage Pool Deficiency, Glycoprotein IIb-IIIa Deficiency, or Impaired Platelet Coagulant Activity --- A Comparison With Scott Syndrome
Blood, March 1, 1997; 89(5): 1599 - 1611.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Molino, D. F. Bainton, J. A. Hoxie, S. R. Coughlin, and L. F. Brass
Thrombin Receptors on Human Platelets. INITIAL LOCALIZATION AND SUBSEQUENT REDISTRIBUTION DURING PLATELET ACTIVATION
J. Biol. Chem., February 28, 1997; 272(9): 6011 - 6017.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. Gawaz, F.-J. Neumann, I. Ott, A. Schiessler, and A. Schomig
Platelet Function in Acute Myocardial Infarction Treated With Direct Angioplasty
Circulation, January 15, 1996; 93(2): 229 - 237.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
C. D. Mazer, A. Hornstein, and J. Freedman
Platelet Activation in Warm and Cold Heart Surgery
Ann. Thorac. Surg., June 1, 1995; 59(6): 1481 - 1486.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1993 by the American Society for Biochemistry and Molecular Biology.